acyl tRNA recognition and cause misreading in bacterial cell-free polypeptide synthesizing systems (9) . A more detailed examination of the mechanism of action has suggested that Hm also interferes with the translocation step in cell-free systems from both bacteria (7) and yeasts (14) .
Most of the aminocyclitol antibiotics can be inactivated by at least one of three enzymatic mechanisms: (i) acetylation, (ii) adenylylation, or (iii) phosphorylation (12) . Enzymes carrying out these reactions and the genes that code for them have been isolated from bacteria resistant to aminocyclitols (12) and from Streptomyces species that produce these antibiotics (3, 22, 33, 34) . The presence of these enzymes in bacteria usually makes the bacteria resistant to the appropriate antibiotic (15) .
Although resistance to Hm has been found in the Hm-producing organism Streptomyces hygroscopicus (22) , there has been no previous report of plasmid-encoded resistance to this antibiotic in enterobacteria. Moreover, none of the numerous aminoglycoside-modifying enzymes reported to date has been shown to use Hm as a substrate. In this paper, we describe the isolation of a gene from Escherichia coli that codes for Hm phosphotransferase activity and confers resistance to Hm.
MATERIALS AND METHODS Bacterial strains and plasmids. All strains used were E. coli K-12 derivatives: W677, W677(JR225) (provided by Julian Davies [11] ), BE783 (N. Rao, unpublished data), BE827 (C600 Hsr-Hsm+ RecA-), and DH1 (provided by D. Hanahan [23] ), BE1065, BE1092, and BE1098 are described in Table 1 . Plasmid pKC7 (resistant to ampicillin [Ap] and neomycin) has been described (29) .
Media and culture conditions. Bacteriological media and growth conditions were as described (24, 28) . Drug-resistant bacteria were selected on plates containing the appropriate antibiotic at the following concentrations: Ap, 100 ,ug/ml; tetracycline, 10 ,ug/ml; neomycin, 25 ,ug/ml; apramycin (Am), 200 ,g/ml; G418, 200 ,ug/ml; and Hm, 200 ,ug/ml.
Plasmid preparation. Plasmid DNAs were prepared by several methods. Rapid preparations were made by an alkaline lysis procedure (4) or by the sodium dodecyl sulfate lysis procedure (13) . Pure DNA preparations were made by the cleared lysate-cesium chloride-ethidium bromide gradient procedure (5) .
Restriction endonuclease digestion and ligation of DNA. Restriction enzyme digests and ligation were done under the conditions specified by the manufacturers (New England Biolabs, Bethesda Research Laboratories, and Boehringer Mannheim Corp.).
Transformations. Transformations were done using published procedures (23) . Transformed cells were grown overnight before selections were done. All recombinant DNA experiments were done under the appropriate containment conditions according to National Institutes of Health guidelines.
Agarose gel electrophoresis. DNA cut with a restriction enzyme was analyzed by electrophoresis on a 1% agarose horizontal slab gel, using Tris-acetate buffer (23) . Electrophoresis was carried out at 5 V/cm for ca. 16 h.
Preparation and assay of aminocyclitol-modifying enzymes. Bacteria were grown and osmotic lysates were prepared by the methods of Haas and Dowding (16) . Enzyme activities were assayed by the phosphocellulose disk method (16) in 50-,ul reactions. The composition of specific reaction mixtures is given below. Reactions were incubated for 15 (ii) Adenylyltraferase. Adenylyltransferase was assayed as described previously (2) (17) . Sampls were washed three times with 0.1 M lithium chloride, dried, and counted in a scintillation counter.
RESULTS
Plasmlddeternnwd resistanc to Hmi li E. coli.
E. coli W67(R22S) harbors a plasmid-coded aminocyclitol-3-N-acetyltransferase that confers resistance to Am and other deoxystreptaminecontaining antibiotics (11) . This strain is also resistant to Ap and tetracycline. Examination of this strain for its susceptibility to Hm indicated that it could grow in the presence of 200 F.g of this drug per ml (minimal inhibitory concentration, 512 pg/ml). Strain W677 lacking the plasmid was inhibited by this concentration of Hm (minimal inhibitory concentration, 64 ,ug/ml).
Plasmid DNA was isolated from E. coli W677(JR225) and used to transform the E. coli K-12 strain BE827 from a Hm-susceptible phenotype to a Hm-resistant phenotype. The plasmid DNA preparation contained two major plasmid species (14.1 and 25 kilobases [kb]). Hmresistant transformants fell into two groups. One group resembled strain W677(JR225) in that it had two major plasmids and was resistant to Ap, tetracycline, Hm, and Am. The other group had only one plasmid (pKC203; 14.1 kb) and was resistant to Hm and Am but was susceptible to Ap and tetracycline. Strain BE827 carrying pKC203 was grown in the presence of Hm, and the plasmid DNA was isolated in high yields. This plasmid DNA was used in the structural characterization described below. The Hm resistance determinant was shown to reside on this plasmid by subsequent plasmid transfer to another Hm-susceptible E. coli K-12 strain, DH1, and by cloning experiments described below.
Genetic three times by BglII. Plasmids pKC203 and pKC7 were cut with BglII and Sall and mixed, and the DNAs were ligated. The ligated DNA was used to transform strain DH1 selecting for Ap-and Am-resistant colonies. All of the transformants were also resistant to Hm, and the recombinant plasmid (pKC222) contained a 2.7-kb BglII-SalI fragment from pKC203 replacing the 1.1-kb BglII-SalI-BamHI-SalI fragment from TnS and a part of pBR322 ( Fig. 1 and 2 ) in pKC7.
DNA segments that confer resistance to Hm or Am were localized by the isolation and characterization of EcoRI and SacI deletions in plasmid pKC222 ( Fig. 1 and 2 ). An EcoRI deletion of pKC222 led to the loss of the Hmresistant phenotype, whereas the Am-resistant phenotype (pKC237) was retained. This experiment localized the DNA segment coding for the Am-resistant phenotype to the 1650-base-pair SalI-EcoRI fragment. SacI deletion of pKC222 led to the loss of Am resistance, whereas Hm resistance (pKC241) was retained. This experiment localized the DNA segment coding for Hm resistance to the 1510-base-pair SacI-BgIII fragment.
Enzymatic basis of resistance to Hm. Cell-free extracts were prepared from representative strains harboring the recombinant plasmids pKC222, pKC237, and pKC241 described above. All plasmids were in the same host strain, DH1. The extract from the Hm-resistant strain carrying pKC241 was assayed for aminocyclitol-modifying enzyme activities, using Hm as the substrate (see above). This extract phosphorylated Hm, but no significant acetylation or adenylylation of this substrate was detected (data not shown).
Each extract was assayed for Am acetyltransferase and Hm phosphotransferase activities (Table 1) . Activity for both enzymes was found in the strain harboring pKC222. Only Am acetyltransferase was found in the Am-resistant strain carrying pKC237, whereas only Hm phosphotransferase activity was found in the Hm-resist-VOL. 24, 1983 on June 17, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AGENTS CHEMOTHER. (26) ished that the phosphate resided on the 4-xyl group adjacent to the methylamino at C-3 rather than on the 6-hydroxyl group nt to the primary amino group at C-1. The ct of modification is thus 4-0-phosphoryl-'he site of modification is indicated by the in Fig. 4 . istrate range. Compounds phosphorylated phosphotransferase enzyme are shown in 2. Destomycins A and B (21), which are y related to Hm, were substrates, as were ;vo analogs A23444 and SS-56C, which in modifications in the cyclitol ring moiety. er hyosamine, deoxystreptamine, nor desacid (Fig. 4) Fig. 5) . A noticeable difference between the susceptible and resistant strains is obvious in Fig. 5 . When either of these strains was preexposed to 1 ,ug of nonradioactive tobramycin per ml for' 20 min, the subsequent uptake of [ 4C]Hm was greatly enhanced. DISCUSSION This paper describes plasmid-encoded resistance to Hm in E. coli. Resistance was detected in a strain (11) carrying plasmid-encoded resistance to other aminocyclitol antibiotics, including the novel drug Am. By gene cloning experiments, the DNA segment coding for Hm resistance was localized to a 1,510-base-pair SacI-BglII fragment in pKC222. By similar experiments, the DNA fragment coding for Am resistance was located adjacent to the Hm resistance gene and on a 1,650-base-pair SalI-EcoRI fragment in pKC222. Recent experiments (T. Ingolia, personal communication) have shown that both of these genes are transcribed in the same direction; Hm resistance is distal to Am resistance.
Resistance to Hm is due to drug inactivation via a 4-O-phosphotransferase. Enzyme activity was demonstrated using the standard phosphocellulose disk assay (16) and independently by radiochromatographic methods. The substrate range for this enzyme is narrow; phosphorylation was limited to Hm and closely related antibiotics, such as the destomycins (21) . There was no phosphorylation of other aminocyclitol antibiotics. This profile is very similar to that reported for the phosphotransferase found in S. hygroscopicus (22) , suggesting a possible relationship between the E. coli and streptomycete enzymes. This might be anticipated since it has been suggested (3) that R factor-determined aminocyclitol-modifying enzymes may have originated in aminocyclitol-producing microorganisms. However, a preliminary report (F. Malpartida and A. Jimenez, Abstr. Fourth Int. Symp. Gen. of Ind. Microorg., 6-11 June 1982, Kyoto, Japan, abstr. no. P-I-3, p. 84) indicates that the molecular weight of the streptomycete enzyme is ca. 60,000. Gel filtration studies (J. Hobbs, Jr., unpublished data) suggest that the molecular weight of the E. coli enzyme is ca. 41,500.
The specificity of the enzyme reported here is likely due to the unique site of modification. Phosphorylation of Hm occurs on the hydroxyl group of hyosamine. This position is not available for modification in other aminocyclitol antibiotics since the'analogous hydroxyl group is substituted, forming the glycosidic linkage between the cyclitol ring and an amino sugar. The unique mechanism is further emphasized by the fact that only one other phosphotransferase (20) reportedly modifies the cyclitol ring of aminocyclitol antibiotics. All other aminocyclitol phosphotransferases modify only the amino sugar moiety of these drugs (30) .
Analogous to modifying enzymes being involved in resistance to other aminocyclitol antibiotics, the presence of Hm phosphotransferase in E. coli results in depressed rates of Hm uptake. Uptake of [14C]Hm by susceptible cells appears to occur by both energy-dependent uptake phases (EDPI and EDPII) as described by Bryan and co-workers (6) . In contrast, uptake by resistant cells (BE1098) seems limited to EDPI (Fig. 5) . The depressed uptake of Hm in resistant cells can be overcome by preexposure to an aminocyclitol antibiotic which is.not modified by the phosphotransferase, e.g., tobramycin. It has been shown (18) that kanamycin can induce an enhanced uptake of dihydrostrepto- (15) . Only further experiments will answer n the question of general utility of the Hm resistance marker for molecular cloning in novel systems.
Hm is one of the few aminocyclitol antibiotics able to kill a variety of procaryotes and eucaryotes. Another aminocyclitol antibiotic, G418, is similar in that it has broad-spectrum activity against bacteria (10), yeasts (19) , plant cells (35) , and animal cells in culture (8, 32 ; R. Santerre, personal communication). G418 resistance can be mediated by a phosphotransferase coded by TnS or Tn9O3 (14, 19) or by an acetyltransferase coded by pKC203 ([10] ; N. Allen, unpublished data). Bacterial G418 resistance genes (phosphotransferase activity) have been expressed in both yeast cells (19) and mammalian cells (8, 32) . Although both G418 resistance and Hm resistance can be used as dominant selectable markers in a wide variety of systems, Hm resistance may be advantageous to use since the phosphotransferase responsible for the resistance has a narrow substrate range.
